<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>1100</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>9461077</PubmedId>
            <Abstract>The structure of the hemagglutinin (HA) of a mutant influenza virus that escapes neutralization by a monoclonal antibody shows that the mutation causes changes in HA structure which avoid an energetically less favorable conformation. However, the structure of the mutant HA.Fab complex indicates that the antibody binds selectively to mutant HA in a wild type-like distorted conformation. The association of an antibody with a less favored HA conformation represents an alternative to previously described mechanisms of escape from neutralization by antibodies.</Abstract>
            <ArticleYear>1998</ArticleYear>
            <ArticlePages>119-23</ArticlePages>
            <ArticleTitle>Antigen distortion allows influenza virus to escape neutralization.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Fleury</LastName>
                    <ForeName>D</ForeName>
                </Author>
                <Author>
                    <LastName>Wharton</LastName>
                    <ForeName>S A</ForeName>
                </Author>
                <Author>
                    <LastName>Skehel</LastName>
                    <ForeName>J J</ForeName>
                </Author>
                <Author>
                    <LastName>Knossow</LastName>
                    <ForeName>M</ForeName>
                </Author>
                <Author>
                    <LastName>Bizebard</LastName>
                    <ForeName>T</ForeName>
                </Author>
            </Authors>
            <Affiliations>Laboratoire d'Enzymologie et Biochimie Structurales, CNRS, Gif-sur-Yvette, France.</Affiliations>
            <ArticleChemicalList>Antibodies, Monoclonal;Antibodies, Viral;Antigen-Antibody Complex;Hemagglutinin Glycoproteins, Influenza Virus;Immunoglobulin Fab Fragments</ArticleChemicalList>
            <ArticleMeshHeadingsList>Antibodies, Monoclonal(chemistry; immunology); Antibodies, Viral(chemistry; immunology); Antibody Affinity; Antigen-Antibody Complex(chemistry; isolation &amp; purification); Crystallography, X-Ray; Hemagglutinin Glycoproteins, Influenza Virus(chemistry; genetics; immunology); Immunoglobulin Fab Fragments; Models, Molecular; Molecular Sequence Data; Mutation; Neutralization Tests; Orthomyxoviridae(chemistry; immunology); Protein Conformation</ArticleMeshHeadingsList>
            <Journal>
                <Volume>5</Volume>
                <Issue>2</Issue>
                <Title>Nature structural biology</Title>
                <Issn>1072-8368</Issn>
                <MedlineTa>Nat Struct Biol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>mAb HC19 epitope of WT influenza X-31 HA1 proteolytic fragment 'HA top'</EpitopeName>
                <EpitopeStructure>
                    <DiscontinuousRegionOnAccessionSequenceMolecule>
                        <ChemicalType>Discontinuous protein residues</ChemicalType>
                        <DiscontinuousResidues>G145, V146, T147, Q148, N149, G150, G151, S152, N153, T171, K172, S173, G174, S175, E206, S209, L210</DiscontinuousResidues>
                        <SourceMolecule>
                            <GenBankId>P03437.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>132504</SourceOrganismId>
                    </DiscontinuousRegionOnAccessionSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>PDB 2VIR, 2VIS and 2VIT</LocationOfData>
                <EpitopeId>104697</EpitopeId>
                <ReferenceRegion>G129, V130, T131, Q132, N133, G134, G135, S136, N137, T155, K156, S157, G158, S159, E190, S193, L194</ReferenceRegion>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Partial Epitope</EpitopeStructureDefines>
                <EpitopeComments>The epitope residues were calculated from the WT antigen-antibody complex structure [PDB: 2VIR] as the antigen residues at 4Ã… atomic distance from the antibody. In [PDB: 2VIS], the antigen is mutated such that contact residue T131 is changed to I131. In [PDB: 2VIT], the antigen is mutated such that contact residue T155 is changed to I155 and an additional contact residue W153 is observed.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figures 1, 2, Table 2 and PDB 2VIR</LocationOfData>
                        <BCellId>1275783</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>132504</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Generation of the monoclonal antibody was previously described in the reference: Daniels et al. (1983) J Gen Virol 64 (Pt 8): 1657-1662 [PMID: 6192202]. Mice were immunized with 8000 HA units of purified virus and boosted i.p. and i.v. 8 weeks later with 32000 HA units. Three days later spleens were removed and cells were fused with SP2/O-Ag14 myeloma cells.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>436</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>3.25</QuantitativeMeasurement>
                            <MeasurementInequality>=</MeasurementInequality>
                            <AssayComments>The epitope of HC19 Fab on the HA top was determined from the crystal structure of the complex. The structures of WT (this structure [PDB: 2VIR]) and T131I mutant (T147I; [PDB: 2VIS]), and T155I mutant (T171I; [PDB: 2VIT]) HAs in complex with the Fab were compared. The T147I mutant, which has a highly reduced affinity for the Fab, binds the antibody in a distorted, unfavorable conformation, which could be the mechanism by which the mutant escapes neutralization.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Fab</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>HC19</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG1</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Lambda</AssayedAntibodyLightChainType>
                            <AssayedAntibodyObject>
                                <MultiChainMolecule>
                                    <ChemicalType>Multi-Chain protein</ChemicalType>
                                    <MoleculeName>HC19</MoleculeName>
                                    <Chain1>
                                        <Molecule>
                                            <GenBankId>1GIG_H</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain1>
                                    <Chain2>
                                        <Molecule>
                                            <GenBankId>1GIG_L</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain2>
                                </MultiChainMolecule>
                            </AssayedAntibodyObject>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Membrane-distal domain of HA1 chain, 'HA top'</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Fragment of Source Antigen</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TLCLGHHAVPNGTLVKTITDDQIEVTNATELVQSSSTGKICNNPHRILDGIDCTLIDALLGDPHCDVFQNETWDLFVERSKAFSNCYPYDVPDYASLRSLVASSGTLEFITEGFTWTGVTQNGGSNACKRGPGSGFFSRLNWLTKSGSTYPVLNVTMPNNDNFDKLYIWGIHHPSTNQEQTSLYVQASGRVTVSTRRSQQTIIPNIGSRPWVRGLSSRISIYWTIVKPGDVLVINSNGNLIAPRGYFKMRTGKSSIMRSDAPIDTCISECITPNGSIPNDKPFQNVNKITYGACPKYVKQN</LinearSequence>
                                        <StartingPosition>28</StartingPosition>
                                        <EndingPosition>328</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P03437.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>132504</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <ThreeDimensionalStructureOfComplex>
                            <ComplexPdbId>2VIR</ComplexPdbId>
                            <AntibodyChain1PdbChain>B</AntibodyChain1PdbChain>
                            <AntibodyChain2PdbChain>A</AntibodyChain2PdbChain>
                            <AntigenChainPdbChain>C</AntigenChainPdbChain>
                            <ViewerFlag>Y</ViewerFlag>
                            <CuratedContacts>
                                <EpitopeResidues>C: ;</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>B: ; A: ;</AntibodyResiduesInteractingWithAntigen>
                            </CuratedContacts>
                            <CalculatedContacts>
                                <EpitopeResidues>C: G129, V130, T131, Q132, N133, G134, G135, S136, N137, T155, K156, S157, G158, S159, E190, S193, L194</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>A: N96; B: L28, I30, S31, W52, A53, G54, N56, N58, Y100, Y102, D103, F105, Y107</AntibodyResiduesInteractingWithAntigen>
                                <ContactAreaForAntigen>612.0</ContactAreaForAntigen>
                                <ContactAreaForAntibody>651.6</ContactAreaForAntibody>
                            </CalculatedContacts>
                        </ThreeDimensionalStructureOfComplex>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 1</LocationOfData>
                        <BCellId>1275968</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>132504</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Generation of the monoclonal antibody was previously described in the reference: Daniels et al. (1983) J Gen Virol 64 (Pt 8): 1657-1662 [PMID: 6192202]. Mice were immunized with 8000 HA units of purified virus and boosted i.p. and i.v. 8 weeks later with 32000 HA units. Three days later spleens were removed and cells were fused with SP2/O-Ag14 myeloma cells.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>250</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>1.0</QuantitativeMeasurement>
                            <AssayComments>The binding of epitope-specific HC19 Fab to the wild type and mutant HAs was measured. The Fab bound the T131l and S157L mutant HAs with a 4000-fold and 500-fold reduced affinity, respectively, compared to that of Fab to wild-type HA.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Fab</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>HC19</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG1</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Lambda</AssayedAntibodyLightChainType>
                            <AssayedAntibodyObject>
                                <MultiChainMolecule>
                                    <ChemicalType>Multi-Chain protein</ChemicalType>
                                    <MoleculeName>HC19</MoleculeName>
                                    <Chain1>
                                        <Molecule>
                                            <GenBankId>1GIG_H</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain1>
                                    <Chain2>
                                        <Molecule>
                                            <GenBankId>1GIG_L</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain2>
                                </MultiChainMolecule>
                            </AssayedAntibodyObject>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Bromelain-released ectodomain of hemagglutinin (BHA)</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Fragment of Source Antigen</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>QDLPGNDNSTATLCLGHHAVPNGTLVKTITDDQIEVTNATELVQSSSTGKICNNPHRILDGIDCTLIDALLGDPHCDVFQNETWDLFVERSKAFSNCYPYDVPDYASLRSLVASSGTLEFITEGFTWTGVTQNGGSNACKRGPGSGFFSRLNWLTKSGSTYPVLNVTMPNNDNFDKLYIWGIHHPSTNQEQTSLYVQASGRVTVSTRRSQQTIIPNIGSRPWVRGLSSRISIYWTIVKPGDVLVINSNGNLIAPRGYFKMRTGKSSIMRSDAPIDTCISECITPNGSIPNDKPFQNVNKITYGACPKYVKQNTLKLATGMRNVPEKQTRGLFGAIAGFIENGWEGMIDGWYGFRHQNSEGTGQAADLKSTQAAIDQINGKLNRVIEKTNEKFHQIEKEFSEVEGRIQDLEKYVEDTKIDLWSYNAELLVALENQHTIDLTDSEMNKLFEKTRRQLRENAEEMGNGCFKIYHKCDNACIESIRNGTYDHDVYRDEALNNRFQIKGV</LinearSequence>
                                        <StartingPosition>17</StartingPosition>
                                        <EndingPosition>521</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P03437.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>132504</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 1</LocationOfData>
                        <BCellId>1275967</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>132504</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Generation of the monoclonal antibody was previously described in the reference: Daniels et al. (1983) J Gen Virol 64 (Pt 8): 1657-1662 [PMID: 6192202]. Mice were immunized with 8000 HA units of purified virus and boosted i.p. and i.v. 8 weeks later with 32000 HA units. Three days later spleens were removed and cells were fused with SP2/O-Ag14 myeloma cells.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>262</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>110000.0</QuantitativeMeasurement>
                            <AssayComments>The binding of epitope-specific HC19 Fab to the HA of wild-type and variant HA mutated at the Fab/HA interface was measured using SPR BIAcore. For HC19 Fab binding to the T131l mutant HA, k on = 540 M^-1s^-1, leading to an overall 4000-fold reduction in affinity for the mutant.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Fab</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>HC19</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG1</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Lambda</AssayedAntibodyLightChainType>
                            <AssayedAntibodyObject>
                                <MultiChainMolecule>
                                    <ChemicalType>Multi-Chain protein</ChemicalType>
                                    <MoleculeName>HC19</MoleculeName>
                                    <Chain1>
                                        <Molecule>
                                            <GenBankId>1GIG_H</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain1>
                                    <Chain2>
                                        <Molecule>
                                            <GenBankId>1GIG_L</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain2>
                                </MultiChainMolecule>
                            </AssayedAntibodyObject>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Bromelain-released ectodomain of hemagglutinin (BHA)</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Fragment of Source Antigen</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>QDLPGNDNSTATLCLGHHAVPNGTLVKTITDDQIEVTNATELVQSSSTGKICNNPHRILDGIDCTLIDALLGDPHCDVFQNETWDLFVERSKAFSNCYPYDVPDYASLRSLVASSGTLEFITEGFTWTGVTQNGGSNACKRGPGSGFFSRLNWLTKSGSTYPVLNVTMPNNDNFDKLYIWGIHHPSTNQEQTSLYVQASGRVTVSTRRSQQTIIPNIGSRPWVRGLSSRISIYWTIVKPGDVLVINSNGNLIAPRGYFKMRTGKSSIMRSDAPIDTCISECITPNGSIPNDKPFQNVNKITYGACPKYVKQNTLKLATGMRNVPEKQTRGLFGAIAGFIENGWEGMIDGWYGFRHQNSEGTGQAADLKSTQAAIDQINGKLNRVIEKTNEKFHQIEKEFSEVEGRIQDLEKYVEDTKIDLWSYNAELLVALENQHTIDLTDSEMNKLFEKTRRQLRENAEEMGNGCFKIYHKCDNACIESIRNGTYDHDVYRDEALNNRFQIKGV</LinearSequence>
                                        <StartingPosition>17</StartingPosition>
                                        <EndingPosition>521</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P03437.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>132504</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3, Table 2 and PDB 2VIS</LocationOfData>
                        <BCellId>1639229</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>132504</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Generation of the monoclonal antibody was previously described in the reference: Daniels et al. (1983) J Gen Virol 64 (Pt 8): 1657-1662 [PMID: 6192202]. Mice were immunized with 8000 HA units of purified virus and boosted i.p. and i.v. 8 weeks later with 32000 HA units. Three days later spleens were removed and cells were fused with SP2/O-Ag14 myeloma cells.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>436</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>3.25</QuantitativeMeasurement>
                            <MeasurementInequality>=</MeasurementInequality>
                            <AssayComments>The epitope of HC19 on the HA top with mutation T131I was determined from the crystal structure of the complex. The structures of WT [PDB: 2VIR] and T131I mutant (T147I; this structure), and T155I mutant (T171I [PDB: 2VIT]) HAs in complex with the Fab were obtained. The T147I mutant (this structure), which has a highly reduced affinity for the Fab, binds the antibody in a distorted, unfavorable conformation, which could be the mechanism by which the mutant escapes neutralization.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Fab</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>HC19</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG1</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Lambda</AssayedAntibodyLightChainType>
                            <AssayedAntibodyObject>
                                <MultiChainMolecule>
                                    <ChemicalType>Multi-Chain protein</ChemicalType>
                                    <MoleculeName>HC19</MoleculeName>
                                    <Chain1>
                                        <Molecule>
                                            <GenBankId>1GIG_H</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain1>
                                    <Chain2>
                                        <Molecule>
                                            <GenBankId>1GIG_L</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain2>
                                </MultiChainMolecule>
                            </AssayedAntibodyObject>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Membrane-distal domain of HA1 chain, T147I (T131I in PDB numbering) mutant.</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Structurally Related</EpitopeRelation>
                                <Object>
                                    <SequenceMoleculeNoNaturalSource>
                                        <ChemicalType>Peptide, no natural source</ChemicalType>
                                        <LinearSequence>TLCLGHHAVPNGTLVKTITDDQIEVTNATELVQSSSTGKICNNPHRILDGIDCTLIDALLGDPHCDVFQNETWDLFVERSKAFSNCYPYDVPDYASLRSLVASSGTLEFITEGFTWTGVIQNGGSNACKRGPGSGFFSRLNWLTKSGSTYPVLNVTMPNNDNFDKLYIWGIHHPSTNQEQTSLYVQASGRVTVSTRRSQQTIIPNIGSRPWVRGLSSRISIYWTIVKPGDVLVINSNGNLIAPRGYFKMRTGKSSIMRSDAPIDTCISECITPNGSIPNDKPFQNVNKITYGACPKYVKQN</LinearSequence>
                                    </SequenceMoleculeNoNaturalSource>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                        <ThreeDimensionalStructureOfComplex>
                            <ComplexPdbId>2VIS</ComplexPdbId>
                            <AntibodyChain1PdbChain>B</AntibodyChain1PdbChain>
                            <AntibodyChain2PdbChain>A</AntibodyChain2PdbChain>
                            <AntigenChainPdbChain>C</AntigenChainPdbChain>
                            <ViewerFlag>Y</ViewerFlag>
                            <Comments>The main structural differences between the this structure and wild type hemagglutinin with HC19 Fab [PDB: 2VIR] are a relative movement of loops 127-132 and 155-161 and a small rotation of the mutant Ile131 side chain. These changes allow the new residue to be accommodated; they also allow a water molecule to access the unpaired carbonyl oxygen of residue 156 and to establish a hydrogen bond with it.</Comments>
                            <CuratedContacts>
                                <EpitopeResidues>C: ;</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>B: ; A: ;</AntibodyResiduesInteractingWithAntigen>
                            </CuratedContacts>
                            <CalculatedContacts>
                                <EpitopeResidues>C: G129, V130, I131, Q132, N133, G134, G135, S136, N137, T155, K156, S157, G158, S159, E190, S193, L194</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>A: N96; B: L28, I30, S31, W52, A53, G54, N56, N58, Y100, Y102, D103, F105, Y107</AntibodyResiduesInteractingWithAntigen>
                                <ContactAreaForAntigen>620.4</ContactAreaForAntigen>
                                <ContactAreaForAntibody>675.9</ContactAreaForAntibody>
                            </CalculatedContacts>
                        </ThreeDimensionalStructureOfComplex>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3, Table 2 and PDB 2VIT</LocationOfData>
                        <BCellId>1639230</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>132504</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Generation of the monoclonal antibody was previously described in the reference: Daniels et al. (1983) J Gen Virol 64 (Pt 8): 1657-1662 [PMID: 6192202]. Mice were immunized with 8000 HA units of purified virus and boosted i.p. and i.v. 8 weeks later with 32000 HA units. Three days later spleens were removed and cells were fused with SP2/O-Ag14 myeloma cells.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>436</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>3.25</QuantitativeMeasurement>
                            <MeasurementInequality>=</MeasurementInequality>
                            <AssayComments>The epitope of HC19 Fab on the HA top of mutantT155I (T171I) was determined from the crystal structure of the complex and compared to the structure of HC19 Fab bound to the WT HA.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Fab</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>HC19</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG1</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Lambda</AssayedAntibodyLightChainType>
                            <AssayedAntibodyObject>
                                <MultiChainMolecule>
                                    <ChemicalType>Multi-Chain protein</ChemicalType>
                                    <MoleculeName>HC19</MoleculeName>
                                    <Chain1>
                                        <Molecule>
                                            <GenBankId>1GIG_H</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain1>
                                    <Chain2>
                                        <Molecule>
                                            <GenBankId>1GIG_L</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain2>
                                </MultiChainMolecule>
                            </AssayedAntibodyObject>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Membrane-distal domain of HA1 chain, T171I (T155I in PDB numbering) mutant</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Structurally Related</EpitopeRelation>
                                <Object>
                                    <SequenceMoleculeNoNaturalSource>
                                        <ChemicalType>Peptide, no natural source</ChemicalType>
                                        <LinearSequence>TITDDQIEVTNATELVQSSSTGKICNNPHRILDGIDCTLIDALLGDPHCDVFQDETWDLFVERSKAFSNCYPYDVPDYASLRSLVASSGTLEFITEGFTWTGVTQNGGSNACKRGPGSGFFSRLNWLIKSGSTYPVLDVTMPNNDNFDKLYIWGIHHPSTNQEQTSLYVQASGRVTVSTRRSQQTIIPNIGSRPWVRGLSSRISIYWTIVKPGDVLVINSNGNLIAPRGYFKMRTGKSSIMRSDAPIDTCISECITPDGSIPNDKPFQNVNKITYGACPKYV</LinearSequence>
                                    </SequenceMoleculeNoNaturalSource>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <ThreeDimensionalStructureOfComplex>
                            <ComplexPdbId>2VIT</ComplexPdbId>
                            <AntibodyChain1PdbChain>B</AntibodyChain1PdbChain>
                            <AntibodyChain2PdbChain>A</AntibodyChain2PdbChain>
                            <AntigenChainPdbChain>C</AntigenChainPdbChain>
                            <ViewerFlag>Y</ViewerFlag>
                            <CuratedContacts>
                                <EpitopeResidues>C: ;</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>B: ; A: ;</AntibodyResiduesInteractingWithAntigen>
                            </CuratedContacts>
                            <CalculatedContacts>
                                <EpitopeResidues>C: G129, V130, T131, Q132, N133, G134, G135, S136, N137, W153, I155, K156, S157, G158, S159, E190, S193, L194</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>B: L28, I30, S31, W52, A53, G54, N56, N58, Y100, Y102, D103, F105, Y107; A: N96;</AntibodyResiduesInteractingWithAntigen>
                                <ContactAreaForAntigen>604.9</ContactAreaForAntigen>
                                <ContactAreaForAntibody>672.1</ContactAreaForAntibody>
                            </CalculatedContacts>
                        </ThreeDimensionalStructureOfComplex>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

